FOR IMMEDIATE RELEASE
inSeption Group Named One of Philadelphia Business Journal’s 2025 Best Places to Work for the Third Consecutive Year
[Audubon, PA – July 9, 2025] — inSeption Group, a clinical outsourcing organization dedicated to elevating standards in drug development, is proud to announce that it has once again been named one of the Philadelphia Business Journal’s Best Places to Work—marking the third consecutive year the company has earned this prestigious recognition.
This honor is especially meaningful because it is driven entirely by employee feedback, collected through confidential surveys that assess trust in leadership, workplace culture, compensation, and benefits. inSeption Group is one of only 10 companies recognized in the large company category for 2025.
“To be named a Best Place to Work for three straight years is an incredible reflection of the culture our team has built,” said Joe Arcangelo, Co-founder and Managing Partner of inSeption Group. “We’ve always believed that if we take care of our people, everything else will follow—and this recognition confirms that belief. It’s personal, it’s meaningful, and it drives us to do even better.”
Brian Sulpizio, Co-founder and Managing Partner, added, “Our mission has always been about restoring pride to the work of drug development, and that starts with creating an environment where people feel connected, empowered, and respected. I couldn’t be prouder of what we’ve built together—and of the people who make inSeption what it is every day.”
To qualify for the Best Places to Work list, companies must be headquartered in or have a physical office in the Greater Philadelphia area and meet a minimum employee count. Finalists are selected solely based on the results of employee surveys administered by Quantum Workplace.
inSeption’s commitment to purpose, accountability, and excellence has remained central as the company continues to grow and expand its services. With a strong emphasis on culture, integrity, and real collaboration, inSeption continues to stand out as an employer of choice in the region and the industry.
For more information about inSeption Group, visit www.inseptiongroup.com
About inSeption Group
Founded in 2011, inSeption Group was created with the vision to restore business trust and confidence in the clinical outsourcing industry. inSeption Group delivers an unparalleled level of service to biotech and pharma companies conducting clinical programs and submissions in highly complex therapeutic areas such as oncology, neurodegenerative disorders, and rare diseases. inSeption expertise spans the clinical research lifecycle including early trial planning, project management, regulatory submissions support, and more. Over time, it has become a home for a subset of professionals who hold themselves to high standards of quality and personal accountability. In the changing landscape of clinical research, we’re creating a new kind of future. One where integrity outweighs self-interest, where transparency cultivates trust, and where people deliver on their promises. For more information, please visit our website at inseptiongroup.com and follow us on LinkedIn.
For more information, please visit our website and follow us on LinkedIn, Instagram, Twitter (@BiotechnologyPa), and Facebook.
Media Contact:
Kristin Morris
Senior Director, Corporate Communications
kmorris@inseptiongroup.com
267-397-8980
870 W Main Street | Landsdale, PA